Dr. Falk Pharma GmbH acquired Kynos Therapeutics Ltd from Epidarex Capital, IP Group Plc and Scottish Investment Bank Limited.
Dr. Falk Pharma GmbH completed the acquisition of Kynos Therapeutics Ltd from Epidarex Capital, IP Group Plc (LSE:IPO) and Scottish Investment Bank Limited on October 29, 2024.